Drug
Contrast Enhanced Ultrasound (CEUS)
Contrast Enhanced Ultrasound (CEUS) is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
completed250%
withdrawn125%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruiting
Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
NCT06775977
completed
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study
NCT03405909
withdrawnphase_4
Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients
NCT03963999
completednot_applicable
Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound
NCT02902562
Clinical Trials (4)
Showing 4 of 4 trials
NCT06775977
Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
NCT03405909
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study
NCT03963999Phase 4
Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients
NCT02902562Not Applicable
Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4